Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
about
Nab-paclitaxel (abraxane)-based chemotherapy to treat elderly patients with advanced non-small-cell lung cancer: a single center, randomized and open-label clinical trial.Human beta-galactoside alpha-2,3-sialyltransferase (ST3Gal III) attenuated Taxol-induced apoptosis in ovarian cancer cells by downregulating caspase-8 activity.[Prognostic factors in 408 elderly lung cancer patients more than 70 years old].[The status and prospects of treatment protocols for elderly patients with non-small cell lung cancer].
P2860
Weekly paclitaxel in elderly patients (aged > or = 70 years) with advanced non-small-cell lung cancer: an alternative choice? Results of a phase II study.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Weekly paclitaxel in elderly p ...... ? Results of a phase II study.
@en
Weekly paclitaxel in elderly patients
@nl
type
label
Weekly paclitaxel in elderly p ...... ? Results of a phase II study.
@en
Weekly paclitaxel in elderly patients
@nl
prefLabel
Weekly paclitaxel in elderly p ...... ? Results of a phase II study.
@en
Weekly paclitaxel in elderly patients
@nl
P2093
P356
P1433
P1476
Weekly paclitaxel in elderly p ...... ? Results of a phase II study.
@en
P2093
Anna Maria Baldelli
David Rossi
Donatella Dennetta
Francesco Graziano
Giuseppina Catalano
Marcello Ugolini
Paolo Alessandroni
Paolo Giordani
Stefano Luzi Fedeli
Vincenzo Catalano
P304
P356
10.3816/CLC.2008.N.043
P407
P577
2008-09-01T00:00:00Z